Unexplained weight loss (UWL), defined as an unintentional loss of more than 5% of body weight within a six-month period, can be a harbinger of serious underlying diseases. The diagnostic approach to UWL can be challenging due to the broad differential diagnosis. This article aims to provide a comprehensive approach to diagnose UWL.
Initial evaluation should focus on a detailed history and physical examination. It's imperative to rule out intentional weight loss, medication side effects, and psychiatric illnesses. A thorough history should include questions about changes in appetite, food intake, and dietary habits. Ask about symptoms of malignancy, endocrine disorders, gastrointestinal diseases, and chronic infections.
Basic laboratory tests, including complete blood count, comprehensive metabolic panel, thyroid function tests, and urinalysis, should be conducted. Additional tests like HIV testing, imaging studies, or endoscopy may be required based on the clinical suspicion.
Geriatric patients may present with weight loss due to physiological changes, decreased appetite, or social factors. In these patients, a diagnosis of exclusion, such as 'frailty' or 'failure to thrive', may be considered after a thorough evaluation.
Management should be directed towards the underlying cause. In cases where no cause is identified, symptomatic management with nutritional support and appetite stimulants may be considered. Regular follow-ups are crucial to monitor the patient's weight and response to treatment.
Diagnosing unexplained weight loss requires a methodical and comprehensive approach. A detailed history, physical examination, and judicious use of diagnostic tests form the cornerstone of evaluation. Timely identification and management of the underlying cause can significantly improve patient outcomes.
1.
New Nanoparticles Can Destroy Undruggable Cancer Proteins
2.
Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer
3.
NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.
4.
Belzutifan Plus Pembro Approved for Adjuvant RCC
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide
2.
Obesity as a major risk factor for cancer
3.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
4.
Advanced Pathways in Oncology for Better Care
5.
Essential Updates in Hematology in Daily Practice
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Understanding Anemia and Its Common Causes
4.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
5.
Early Cancer Detection Saves Lives
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation